甲基和金属离子结合甲基酸复合物的细胞毒性和ROS生成活性
Viktor A Timoshnikov1, Irina A Slepneva1, Olga A Chinak1,2
1Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Institutskaya St. 3, 630090, Novosibirsk, Russia.
概括
新的 antraquinone (AQ) 衍生物显示出作为抗癌药物的前景. 研究人员开发了Q1的铁和铜合物,发现铜复合物对肺癌和乳腺癌细胞有效,具有减少反应性氧物种 (ROS) 生成.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类素 (AQs) 是强大的化疗药物,但由于反应性氧物种 (ROS) 引起心脏毒性.
- 开发更安全,更有效的抗癌剂是关键的研究优先事项.
- 修改AQ结构以减轻毒性,同时保持有效性至关重要.
研究的目的:
- 评估一种新型的人类素衍生物Q1及其铁 (Fe-Q1) 和铜 (Cu-Q1) 合物复合物的细胞毒性和ROS生成.
- 评估这些复合物的潜力,作为改善的抗癌药物,并减少副作用.
主要方法:
- 用A549 (肺癌) 和MDA-MB-231 (乳腺癌) 细胞系来评估细胞毒性.
- 通过在A549,MDA-MB-231和MOLT-4 (T淋巴细胞) 细胞系中使用EPR回旋捕获来研究反应性氧物种 (ROS) 的产生.
- 研究了Q1及其复合物的氧化还原活性和细胞透.
主要成果:
- Q1化合物及其铜复合物 (Cu-Q1) 对肺癌和乳腺癌细胞系表现出显著的细胞毒性.
- 铁复合物 (Fe-Q1) 没有显著的细胞毒性活性.
- Q1通过半农基形成产生ROS,有效地穿透细胞.
- Fe-Q1复合体的形成显著减缓了ROS生成动力学,可能是由于细胞膜透率降低.
结论:
- 与原始化合物相比,Q1 (Cu-Q1) 的铜酸盐表现出强大的抗癌活性,具有潜在的减少ROS介导毒性.
- 铁酸盐 (Fe-Q1) 是不活跃的,这表明金属化显著改变生物活性.
- 需要进一步研究Cu-Q1作为肺癌和乳腺癌的治疗候选药物.
关键词:
A54949 是一个A549的字体.人类胺 (Anthraquinones) 是一种胺.癌细胞 癌细胞 癌细胞细胞毒性活动的细胞毒性.在EPR中使用EPR.在MDA-MB-231中使用.在MOLT-4中使用.金属复合物的金属复合物这就是ROSOS ROS.旋转陷是一种自旋陷.更多相关视频
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
9.1K
05:35Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography
Published on: January 17, 2020
7.3K
相关概念视频
00:56Extraction: Advanced Methods
432
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
432
01:30The Electron Transport Chain
16.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.3K
01:19Complexation Equilibria: The Chelate Effect
475
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
475
01:46Electron Transport Chain: Complex I and II
12.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
01:26EDTA: Auxiliary Complexing Reagents
564
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
564
01:17Antidotes
618
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
618